180 related articles for article (PubMed ID: 30325179)
1. Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis.
Vanbrabant T; Fassnacht M; Assie G; Dekkers OM
Eur J Endocrinol; 2018 Dec; 179(6):429-436. PubMed ID: 30325179
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Glenn JA; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Am J Surg; 2016 Jun; 211(6):1106-13. PubMed ID: 26810939
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.
Berruti A; Libè R; Laganà M; Ettaieb H; Sukkari MA; Bertherat J; Feelders RA; Grisanti S; Cartry J; Mazziotti G; Sigala S; Baudin E; Haak H; Habra MA; Terzolo M
Eur J Endocrinol; 2019 May; 180(5):311-320. PubMed ID: 30970324
[TBL] [Abstract][Full Text] [Related]
4. The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study.
Sada A; Foster TR; Al-Ward R; Sawani S; Charchar H; Pishdad R; Ben-Shlomo A; Dy BM; Lyden ML; Bergsland E; Jasim S; Raj N; Shank JB; Hamidi O; Hamrahian AH; Chambô JL; Srougi V; Fragoso MC; Graham PH; Habra MA; Bancos I; McKenzie TJ
Surgery; 2024 Jan; 175(1):80-89. PubMed ID: 37945477
[TBL] [Abstract][Full Text] [Related]
5. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Adrenocortical Carcinoma.
Solak M; Kraljević I; Zibar Tomšić K; Kaštelan M; Kakarigi L; Kaštelan D;
Endocr Res; 2021; 46(2):74-79. PubMed ID: 33416409
[TBL] [Abstract][Full Text] [Related]
7. Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma.
Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
J Cell Mol Med; 2021 Nov; 25(21):10061-10072. PubMed ID: 34664400
[TBL] [Abstract][Full Text] [Related]
8. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.
Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E
J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes.
Kendrick ML; Curlee K; Lloyd R; Farley DR; Grant CS; Thompson GB; Rowland C; Young WF; van Heerden JA
Surgery; 2002 Dec; 132(6):1008-11; discussion 1012. PubMed ID: 12490848
[TBL] [Abstract][Full Text] [Related]
10. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma.
Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF
Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054
[TBL] [Abstract][Full Text] [Related]
11. Comparative performances of nomograms and conditional survival after resection of adrenocortical cancer.
de Jong MC; Khan S; Christakis I; Weaver A; Mihai R
BJS Open; 2021 Jan; 5(1):. PubMed ID: 33609384
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.
Nakanishi S; Fukushima Y; Inokuchi J; Hakariya T; Kakinoki H; Enokida H; Chikui K; Matsuoka H; Shin T; Mukai S; Kamba T; Eto M; Imamura R; Noguchi M; Igawa T; Haga N; Kamoto T; Fujimoto N; Saito S
Int J Urol; 2024 May; 31(5):484-491. PubMed ID: 38193650
[TBL] [Abstract][Full Text] [Related]
13. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M
Eur J Endocrinol; 2019 Jun; 180(6):387-396. PubMed ID: 30991359
[TBL] [Abstract][Full Text] [Related]
15. New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
Puglisi S; Calabrese A; Ferraù F; Violi MA; Laganà M; Grisanti S; Ceccato F; Scaroni C; Di Dalmazi G; Stigliano A; Altieri B; Canu L; Loli P; Pivonello R; Arvat E; Morelli V; Perotti P; Basile V; Berchialla P; Urru S; Fiori C; Porpiglia F; Berruti A; Pia A; Reimondo G; Cannavò S; Terzolo M
J Clin Endocrinol Metab; 2023 Sep; 108(10):2517-2525. PubMed ID: 37022947
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Adrenocortical Carcinoma.
Vaidya A; Nehs M; Kilbridge K
Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis.
Abiven-Lepage G; Coste J; Tissier F; Groussin L; Billaud L; Dousset B; Goffinet F; Bertagna X; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2010 Nov; 163(5):793-800. PubMed ID: 20699382
[TBL] [Abstract][Full Text] [Related]
18. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
[TBL] [Abstract][Full Text] [Related]
19. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
Kamenicky P; Houdoin L; Ferlicot S; Salenave S; Brailly S; Droupy S; Meduri G; Sasano H; Suzuki T; Young J; Chanson P
Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424
[TBL] [Abstract][Full Text] [Related]
20. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
Alexandraki KI; Kaltsas GA; le Roux CW; Fassnacht M; Ajodha S; Christ-Crain M; Akker SA; Drake WM; Edwards R; Allolio B; Grossman AB
Clin Endocrinol (Oxf); 2010 Mar; 72(3):305-11. PubMed ID: 19473175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
